XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting and Reporting Policies (Tables)
 9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Condensed Financial Statements

The condensed consolidated financial statements include all accounts of the entities as of the reporting period ending dates and for the reporting periods as follows:

 

Name of condensed consolidated

subsidiary

 

State or other

jurisdiction of
incorporation or
organization

 

Date of

incorporation

or formation

  Attributable
interest as of
September 30, 2025		   Attributable
interest as of
December 31, 2024		 
               
Global BioMedical, Inc.  Nevada  April 18, 2017   90.9%   90.9%
Global BioLife, Inc.  Nevada  April 14, 2017   81.8%   81.8%
BioLife Sugar, Inc  Nevada  April 23, 2018   90.9%   90.9%
Happy Sugar Inc  Nevada  August 17, 2018   81.8%   81.8%
Sweet Sense Inc.  Nevada  April 30, 2018   95.5%   95.5%
Global Sugar Solutions Inc.  Nevada  November 7, 2019   100%   100%
Impact Biolife Science, Inc.   Nevada   April 13, 2021     100 %     100 %
DSS Biomedical International, Inc.   Nevada   April 9, 2021     100  %     100 %
DSS Biolife International, Inc.   Nevada   April 9, 2021     100  %     100 %

 

As of September 30, 2025, and December 31, 2024, the aggregate noncontrolling interest was equity of $2,956,000 and $2,978,000, respectively, which are separately disclosed on the Condensed Consolidated Balance Sheets.